Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
40,000 visitors and representatives of more than 80 countries set to visit the show
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
The approval further strengthens the Potassium Chloride franchise for the company.
Innovative Capsugel Enprotect capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Plans to double its manufacturing footprint to bolster the growth
Subscribe To Our Newsletter & Stay Updated